KERATO LIMITED SIGNS WITH QUEBEC PSO GRANT

AI SummaryClose X

BSF Enterprise PLC's subsidiary, Kerato Limited, has secured a CAD 663,000 PSO Grant from the Quebec Ministry of Economy, Innovation and Energy, with Kerato co-funding approximately 55% over 18 months, to advance veterinary trials for its LiQD Cornea product and support North American market entry. This funding will cover safety and biocompatibility testing, veterinary clinical trials at the University of Montreal, and regulatory and intellectual property support, aiming for an initial animal health product launch in Canada in Q1 2027. The program also seeks to de-risk future human clinical development by generating essential safety data and defining regulatory pathways, with early revenues from the animal health segment expected to fund ongoing human clinical preparations.

Disclaimer*

UK 100

Latest directors dealings